Search

Your search keyword '"Rees, Matthew"' showing total 963 results

Search Constraints

Start Over You searched for: Author "Rees, Matthew" Remove constraint Author: "Rees, Matthew"
963 results on '"Rees, Matthew"'

Search Results

1. Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma

2. Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition

3. Directed conservation of the world’s reef sharks and rays

4. Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

5. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

7. Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

8. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.

11. Targeting ROS production through inhibition of NADPH oxidases

12. The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity

16. Preparation and electrochemical characterisation of anion exchange polymer coated electrodes towards sensing applications

19. Counting the bodies : Estimating the numbers and spatial variation of Australian reptiles, birds and mammals killed by two invasive mesopredators

20. Screening in serum-derived medium reveals differential response to compounds targeting metabolism

21. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome

23. The insistent image, and, The Word : an exploration of the creative force of insistent mental imagery in the writing of short stories

25. An organocatalytic asymmetric approach to chiral proline derived diketopiperazines related to the prenylated indole alkaloid family

26. Bispecific antibody targets and therapies in multiple myeloma.

28. Targeted Degradation of CDK9 Potently Disrupts the MYC Transcriptional Network

29. Predictors of timely and deep renal responses in AL amyloidosis

30. Predictors of timely and deep cardiac responses in AL amyloidosis

33. Data from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

34. Supplementary Data File 2 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

35. Supplementary Figure 15 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

36. Supplementary Table 1 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

37. Supplementary Data File 1 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

38. Supplementary Methods from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

39. Supplementary Figure 2 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

40. Supplementary Table 2 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

41. Supplementary Figure 9 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

42. Supplementary Data File 3 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

43. Supplementary Figure 6 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

44. Supplementary Figure 3 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

45. Supplementary Figure 4 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

46. Supplementary Figure 8 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

47. Supplementary Figure 5 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

48. Supplementary Figure 7 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

Catalog

Books, media, physical & digital resources